Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01106794 · ClinicalTrials.gov registry record
Molecular Analysis of Samples From Patients With Diffuse Intrinsic Pontine Glioma and Brainstem Glioma
A clinical trial of Diffuse Intrinsic Pontine Glioma and Brainstem Glioma, sponsored by Children's National Research Institute.
- Recruiting
- Registry status
- 100
- Enrollment target
- 1
- Study location
NCT01106794 is a study of Diffuse Intrinsic Pontine Glioma and Brainstem Glioma that is actively recruiting participants, run by Children's National Research Institute. The registered enrollment target is 100 participants, below the 132-participant average among 28 other Diffuse Intrinsic Pontine Glioma trials with a reported enrollment target (24% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01106794, a study of Diffuse Intrinsic Pontine Glioma and Brainstem Glioma, is actively recruiting participants, sponsored by Children's National Research Institute.
- RECRUITING
- Registry status
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to prospectively collect specimens from pediatric patients with diffuse intrinsic pontine glioma or brainstem glioma, either during therapy or at autopsy, in order to characterize the molecular abnormalities of this tumor.
Conditions Studied
Study Locations (1)
District of Columbia
- Children's National Medical Center - Washington D.C.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2010-04 |
| Est. Completion | 2030-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01106794
The ClinicalTrials.gov registry entry for NCT01106794 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 132-participant average among 28 other Diffuse Intrinsic Pontine Glioma trials with a reported enrollment target (24% lower). The listed sponsor is Children's National Research Institute, which has 92 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Diffuse Intrinsic Pontine Glioma appearing as the primary indexed condition, and to 0 interventions.
NCT01106794 reports 1 study location spanning 1 distinct geographic area - top geographies include District of Columbia.
Frequently Asked Questions
What is clinical trial NCT01106794 about?
NCT01106794 is a clinical study titled "Molecular Analysis of Samples From Patients With Diffuse Intrinsic Pontine Glioma and Brainstem Glioma". The purpose of this study is to prospectively collect specimens from pediatric patients with diffuse intrinsic pontine glioma or brainstem glioma, either during therapy or at autopsy, in order to characterize the molecular abnormalities of this tumor.
What is the current status of trial NCT01106794?
This trial is currently recruiting. The enrollment target is 100 participants. The study started on 2010-04. Estimated completion is 2030-04.
What conditions does trial NCT01106794 study?
This clinical trial studies the following conditions: Diffuse Intrinsic Pontine Glioma, Brainstem Glioma.
Who is sponsoring clinical trial NCT01106794?
This trial is sponsored by Children's National Research Institute, which has 92 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01106794 being conducted?
This trial has 1 study location across District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diffuse Intrinsic Pontine Glioma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
FUS Etoposide for DMG
RECRUITING · Phase 1
-
Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion
RECRUITING · Early Phase 1
-
Atovaquone Combined With Radiation in Children With Malignant Brain Tumors
RECRUITING · Phase 1
-
PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma
RECRUITING · Phase 2
-
A Pilot Study of Larotrectinib for Newly-Diagnosed High-Grade Glioma With NTRK Fusion
RECRUITING · Early Phase 1
-
Treatment of Relapsed/Refractory Intracranial Glioma in Patients Under 22 Years of Age
RECRUITING · Phase 1
Explore more on PlainTrial
Diffuse Intrinsic Pontine Glioma
All registered trials for this condition
Brainstem Glioma
All registered trials for this condition
District of Columbia
All trials with a study site in District of Columbia
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.